Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akira Satou

Showing results (81-90 of 117) with videos related to

Pageof 12
Sort By:
Cancer Science|July 26, 2021
Improving function of cytotoxic T-lymphocytes by transforming growth factor-β inhibitor in oral squamous cell carcinomaYutaro Kondo, Susumu Suzuki, Taishi Takahara, et al.
Pathology International|April 1, 2018
An autopsy case report: Differences in radiological images correlate with histology in Erdheim-Chester diseaseYuuki Ohara, Seiichi Kato, Daisuke Yamashita, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 7, 2019
Methotrexate-associated lymphoproliferative disorders of T-cell phenotype: clinicopathological analysis of 28 casesAkira Satou, Tetsuya Tabata, Hiroaki Miyoshi, et al.
Cancer Medicine|November 19, 2018
Clinicopathological analysis of primary intestinal diffuse large B-cell lymphoma: Prognostic evaluation of CD5, PD-L1, and Epstein-Barr virus on tumor cellsEri Ishikawa, Seiichi Kato, Kazuyuki Shimada, et al.
International Journal of Molecular Sciences|April 23, 2022
In Situ PD-L1 Expression in Oral Squamous Cell Carcinoma Is Induced by Heterogeneous Mechanisms among PatientsYutaro Kondo, Susumu Suzuki, Shoya Ono, et al.
Scientific Reports|December 15, 2022
Trametinib improves Treg selectivity of anti-CCR4 antibody by regulating CCR4 expression in CTLs in oral squamous cell carcinomaShoya Ono, Susumu Suzuki, Yutaro Kondo, et al.
International Journal of Molecular Sciences|January 21, 2023
Establishment of Mucoepidermoid Carcinoma Cell Lines from Surgical and Recurrence Biopsy SpecimensShunpei Yamanaka, Susumu Suzuki, Hideaki Ito, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|September 13, 2021
Diagnostic utility of programmed cell death ligand 1 (clone SP142) immunohistochemistry for malignant lymphoma and lymphoproliferative disorders: A brief reviewAyako Sakakibara, Kei Kohno, Eri Ishikawa, et al.
Histopathology|January 31, 2018
Immunohistochemical assessment of the diagnostic utility of PD-L1: a preliminary analysis of anti-PD-L1 antibody (SP142) for lymphoproliferative diseases with tumour and non-malignant Hodgkin-Reed-Sternberg (HRS)-like cellsAyako Sakakibara, Kei Kohno, Ahmed E Eladl, et al.
The American Journal of Surgical Pathology|April 30, 2020
Reappraisal of Primary Epstein-Barr Virus (EBV)-positive Diffuse Large B-Cell Lymphoma of the Gastrointestinal Tract: Comparative Analysis Among Immunosuppressed and Nonimmunosuppressed Stage I and II-IV PatientsShouhei Miyagi, Eri Ishikawa, Masanao Nakamura, et al.
Pageof 12

Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
Cancer Science|July 26, 2021
Improving function of cytotoxic T-lymphocytes by transforming growth factor-β inhibitor in oral squamous cell carcinomaYutaro Kondo, Susumu Suzuki, Taishi Takahara, et al.
Pathology International|April 1, 2018
An autopsy case report: Differences in radiological images correlate with histology in Erdheim-Chester diseaseYuuki Ohara, Seiichi Kato, Daisuke Yamashita, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 7, 2019
Methotrexate-associated lymphoproliferative disorders of T-cell phenotype: clinicopathological analysis of 28 casesAkira Satou, Tetsuya Tabata, Hiroaki Miyoshi, et al.
Cancer Medicine|November 19, 2018
Clinicopathological analysis of primary intestinal diffuse large B-cell lymphoma: Prognostic evaluation of CD5, PD-L1, and Epstein-Barr virus on tumor cellsEri Ishikawa, Seiichi Kato, Kazuyuki Shimada, et al.
International Journal of Molecular Sciences|April 23, 2022
In Situ PD-L1 Expression in Oral Squamous Cell Carcinoma Is Induced by Heterogeneous Mechanisms among PatientsYutaro Kondo, Susumu Suzuki, Shoya Ono, et al.
Scientific Reports|December 15, 2022
Trametinib improves Treg selectivity of anti-CCR4 antibody by regulating CCR4 expression in CTLs in oral squamous cell carcinomaShoya Ono, Susumu Suzuki, Yutaro Kondo, et al.
International Journal of Molecular Sciences|January 21, 2023
Establishment of Mucoepidermoid Carcinoma Cell Lines from Surgical and Recurrence Biopsy SpecimensShunpei Yamanaka, Susumu Suzuki, Hideaki Ito, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|September 13, 2021
Diagnostic utility of programmed cell death ligand 1 (clone SP142) immunohistochemistry for malignant lymphoma and lymphoproliferative disorders: A brief reviewAyako Sakakibara, Kei Kohno, Eri Ishikawa, et al.
Histopathology|January 31, 2018
Immunohistochemical assessment of the diagnostic utility of PD-L1: a preliminary analysis of anti-PD-L1 antibody (SP142) for lymphoproliferative diseases with tumour and non-malignant Hodgkin-Reed-Sternberg (HRS)-like cellsAyako Sakakibara, Kei Kohno, Ahmed E Eladl, et al.
The American Journal of Surgical Pathology|April 30, 2020
Reappraisal of Primary Epstein-Barr Virus (EBV)-positive Diffuse Large B-Cell Lymphoma of the Gastrointestinal Tract: Comparative Analysis Among Immunosuppressed and Nonimmunosuppressed Stage I and II-IV PatientsShouhei Miyagi, Eri Ishikawa, Masanao Nakamura, et al.
Pageof 12